Shaker R. Dakhil
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 2%
- Cancer Research top 0.2%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Charles L. LoprinziPaul J. NovotnyJeff A. SloanKendrith M. RowlandNorman WolmarkRichard I. FisherTom R. FitchJames A. Mailliard
- Topics
- Cancer Treatment and Pharmacology (68 papers)Colorectal Cancer Treatments and Studies (61 papers)Lung Cancer Treatments and Mutations (57 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Shaker R. Dakhil
306 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 9.2k
- Pulmonary and Respiratory Medicine 5.1k
- Molecular Biology 3.3k
- Cancer Research 3.1k
- Pathology and Forensic Medicine 3.0k
Countries citing papers authored by Shaker R. Dakhil
This map shows the geographic impact of Shaker R. Dakhil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaker R. Dakhil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaker R. Dakhil more than expected).
Fields of papers citing papers by Shaker R. Dakhil
This network shows the impact of papers produced by Shaker R. Dakhil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaker R. Dakhil. The network helps show where Shaker R. Dakhil may publish in the future.
Co-authorship network of co-authors of Shaker R. Dakhil
This figure shows the co-authorship network connecting the top 25 collaborators of Shaker R. Dakhil. A scholar is included among the top collaborators of Shaker R. Dakhil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaker R. Dakhil. Shaker R. Dakhil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 22 | |
| 6 | 33 | |
| 7 | 10 | |
| 8 | Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trialbreakdown → | 507 |
| 9 | 32 | |
| 10 | 123 | |
| 11 | 111 | |
| 12 | 92 | |
| 13 | 43 | |
| 14 | 127 | |
| 15 | 52 | |
| 16 | 26 | |
| 17 | 402 | |
| 18 | 86 | |
| 19 | 58 | |
| 20 | 41 |
About Shaker R. Dakhil
Shaker R. Dakhil is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 313 papers that have together received 16.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (68 papers), Colorectal Cancer Treatments and Studies (61 papers) and Lung Cancer Treatments and Mutations (57 papers). The work is most often cited by research in Oncology (9.2k citations), Cancer Research (3.1k citations) and Pathology and Forensic Medicine (3.0k citations). Shaker R. Dakhil has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Charles L. Loprinzi, Paul J. Novotny, Jeff A. Sloan, Kendrith M. Rowland, Norman Wolmark, Richard I. Fisher, Tom R. Fitch, James A. Mailliard, Julie R. Gralow and Patrick J. Flynn. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.